No | Primary DI | Version or Model | Catalog Number | Device Description | Product Code | Product Code Name | Device Class | Brand Name |
---|---|---|---|---|---|---|---|---|
1 | 00358468638014 | 6380-01 | Barrier, Absorbable, Adhesion | MCN | BARRIER, ABSORABLE, ADHESION | Seprafilm® 4-section | ||
2 | 20358468019039 | LG100 | Occluder, Internal Vessel, Temporary | OBC | Occluder, internal vessel, temporary | 3 | LeGoo® LG100 | |
3 | 00358468000064 | 785362 | OLIPUDASE 20MG/5ML MEDSU VL1 DIAG US | MVU | Reagents, Specific, Analyte | 1 | OLIPUDASE 20MG/5ML MEDSU VL1 DIAG US | |
4 | 20358468019046 | LG250 | Occluder, Internal Vessel, Temporary | OBC | Occluder, internal vessel, temporary | 3 | LeGoo® LG250 | |
5 | 00358468000071 | 762617 | GAA-1 ANTIBODY 1MG/1ML MEDSU VL1 DIAG US | MVU | Reagents, Specific, Analyte | 1 | GAA-1 ANTIBODY 1MG/1ML MEDSU VL1 DIAG US | |
6 | 00358468000040 | 762621 | CEREZYME 400IU MEDSU VL1 DIAG US | MVU | Reagents, Specific, Analyte | 1 | CEREZYME 400IU MEDSU VL1 DIAG US | |
7 | 00358468019103 | 002390 | Acid, Hyaluronic, Intraarticular | MOZ | Acid, hyaluronic, intraarticular | Synvisc® | ||
8 | 00358468000057 | 785361 | NEOGAA AVALGLUCO 100MG/20ML MEDSU VL1 US | MVU | Reagents, Specific, Analyte | 1 | NEOGAA AVALGLUCO 100MG/20ML MEDSU VL1 US | |
9 | 20358468019114 | 002401 | Acid, Hyaluronic, Intraarticular | MOZ | Acid, hyaluronic, intraarticular | 3 | Synvisc-One® | |
10 | 00358468430120 | 4301-02 | Barrier, Absorbable, Adhesion | MCN | BARRIER, ABSORABLE, ADHESION | Seprafilm® | ||
11 | 00358468000033 | 762620 | FABRAZYME 35MG/7ML VL1 DIAG US | MVU | Reagents, Specific, Analyte | 1 | FABRAZYME 35MG/7ML VL1 DIAG US | |
12 | 00358468000019 | 762618 | ALDURAZYME 2.9 MG/5ML MEDSU VL1 DIAG US | MVU | Reagents, Specific, Analyte | 1 | ALDURAZYME 2.9 MG/5ML MEDSU VL1 DIAG US | |
13 | 00358468664211 | 6642-01 | Barrier, Absorbable, Adhesion | MCN | BARRIER, ABSORABLE, ADHESION | Seprafilm® Small Incision | ||
14 | 00358468664112 | 6641-01 | Barrier, Absorbable, Adhesion | MCN | BARRIER, ABSORABLE, ADHESION | Seprafilm® Single Site | ||
15 | 00358468000026 | 762619 | MYOZYME 50MG/10ML MEDSU VL1 DIAG US | MVU | Reagents, Specific, Analyte | 1 | MYOZYME 50MG/10ML MEDSU VL1 DIAG US |
No | Primary DI | Version or Model | Catalog Number | Device Description | Brand Name | Organization Name |
---|---|---|---|---|---|---|
1 | 10884521057906 | SSK01 | SSK01 | Adhesion Barrier System | SprayShield | COVIDIEN LP |
2 | 10705031147843 | 4350XL | 4350XL | Absorbable Adhesion Barrier, Oxidized Regenerated Cellulose | GYNECARE INTERCEED | ETHICON, LLC |
3 | 10705031005396 | 4350 | 4350 | Absorbable Adhesion Barrier, Oxidized Regenerated Cellulose | GYNECARE INTERCEED | ETHICON SÀRL |
4 | 05413765589652 | 508602 | 508602 | Seprafilm Adhesion Barrier (membrane) is a sterile, bioresorbable, translucent a Seprafilm Adhesion Barrier (membrane) is a sterile, bioresorbable, translucent adhesion barrier composed of two anionic polysaccharides, sodium hyaluronate (HA) and carboxymethylcellulose (CMC). | SEPRAFILM | BAXTER HEALTHCARE CORPORATION |
5 | 05413765589645 | 638001 | 638001 | Seprafilm Adhesion Barrier (membrane) is a sterile, bioresorbable, translucent a Seprafilm Adhesion Barrier (membrane) is a sterile, bioresorbable, translucent adhesion barrier composed of two anionic polysaccharides, sodium hyaluronate (HA) and carboxymethylcellulose (CMC). | SEPRAFILM | BAXTER HEALTHCARE CORPORATION |
6 | 05413765589638 | 664101 | 664101 | Seprafilm Adhesion Barrier (membrane) is a sterile, bioresorbable, translucent a Seprafilm Adhesion Barrier (membrane) is a sterile, bioresorbable, translucent adhesion barrier composed of two anionic polysaccharides, sodium hyaluronate (HA) and carboxymethylcellulose (CMC). | SEPRAFILM | BAXTER HEALTHCARE CORPORATION |
7 | 05413765589621 | 664201 | 664201 | Seprafilm Adhesion Barrier (membrane) is a sterile, bioresorbable, translucent a Seprafilm Adhesion Barrier (membrane) is a sterile, bioresorbable, translucent adhesion barrier composed of two anionic polysaccharides, sodium hyaluronate (HA) and carboxymethylcellulose (CMC). | SEPRAFILM | BAXTER HEALTHCARE CORPORATION |
8 | 05413765589614 | 430102 | 430102 | Seprafilm Adhesion Barrier (membrane) is a sterile, bioresorbable, translucent a Seprafilm Adhesion Barrier (membrane) is a sterile, bioresorbable, translucent adhesion barrier composed of two anionic polysaccharides, sodium hyaluronate (HA) and carboxymethylcellulose (CMC). | SEPRAFILM | BAXTER HEALTHCARE CORPORATION |
9 | 00358468664211 | 6642-01 | Barrier, Absorbable, Adhesion | Seprafilm® Small Incision | GENZYME CORPORATION | |
10 | 00358468664112 | 6641-01 | Barrier, Absorbable, Adhesion | Seprafilm® Single Site | GENZYME CORPORATION | |
11 | 00358468638014 | 6380-01 | Barrier, Absorbable, Adhesion | Seprafilm® 4-section | GENZYME CORPORATION | |
12 | 00358468508621 | 5086-02 | Barrier, Absorbable, Adhesion | Seprafilm® Procedure Pack | GENZYME CORPORATION | |
13 | 00358468430120 | 4301-02 | Barrier, Absorbable, Adhesion | Seprafilm® | GENZYME CORPORATION | |
14 | 00085412086217 | 0600041 | 0600041 | Adept (4% icodextrin solution) is a single use, sterile, clear, colorless to pal Adept (4% icodextrin solution) is a single use, sterile, clear, colorless to pale yellowfluid for intraperitoneal administration, containing icodextrin at a concentration of 4%w/v in an electrolyte solution, presented in a flexible polyvinylchloride bag.Adept is indicated for use intraperitoneally as an adjunct to good surgical technique forthe reduction of post-surgical adhesions in patients undergoing gynecologicallaparoscopic adhesiolysis. | Adept Adhesion Reduction Solution | BAXTER INTERNATIONAL INC. |